| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | small GTPase binding | KNTC1 EPS8 MYCBP2 RABGAP1 CHML FMNL2 HPS4 FGD3 MAPKAP1 IPO7 NSF DOCK9 DOCK10 FMNL3 IPO13 XPO7 | 5.88e-07 | 321 | 220 | 16 | GO:0031267 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.18e-06 | 18 | 220 | 5 | GO:0015278 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.32e-06 | 3 | 220 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | GTPase binding | KNTC1 EPS8 MYCBP2 RABGAP1 CHML FMNL2 HPS4 FGD3 MAPKAP1 IPO7 NSF DOCK9 DOCK10 FMNL3 IPO13 XPO7 | 2.63e-06 | 360 | 220 | 16 | GO:0051020 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.09e-05 | 31 | 220 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.86e-05 | 33 | 220 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP6V0A1 TCIRG1 RYR1 RYR2 ITPR1 ITPR2 ITPR3 SLC22A6 SLC22A8 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A SLC25A11 ABCC2 ATP13A4 SLC9A8 TMEM63C OCA2 SLC25A12 ATP2B3 | 3.54e-05 | 758 | 220 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | NAD+-protein-arginine ADP-ribosyltransferase activity | 4.47e-05 | 7 | 220 | 3 | GO:0106274 | |
| GeneOntologyMolecularFunction | transporter activity | ATP6V0A1 ABCA12 BAK1 TCIRG1 BCS1L RYR1 RYR2 ITPR1 ITPR2 ITPR3 SLC22A6 SLC22A8 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A SLC25A11 ABCC2 ATP13A4 SLC9A8 SLC35C2 APOF TMEM63C GRID2 APOB OCA2 CNNM1 SLC25A12 ATP2B3 | 8.45e-05 | 1289 | 220 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP6V0A1 ABCA12 BAK1 TCIRG1 BCS1L RYR1 RYR2 ITPR1 ITPR2 ITPR3 SLC22A6 SLC22A8 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A SLC25A11 ABCC2 ATP13A4 SLC9A8 SLC35C2 TMEM63C GRID2 OCA2 CNNM1 SLC25A12 ATP2B3 | 1.07e-04 | 1180 | 220 | 28 | GO:0022857 |
| GeneOntologyMolecularFunction | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity | 1.21e-04 | 2 | 220 | 2 | GO:0050659 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.06e-04 | 109 | 220 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | Roundabout binding | 2.70e-04 | 12 | 220 | 3 | GO:0048495 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 3.57e-04 | 31 | 220 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.39e-04 | 14 | 220 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH6 ATP6V0A1 CCT3 ERCC6L ABCA12 TCIRG1 BCS1L ABCC2 DNAH5 DNHD1 ATP13A4 NSF DYNC2H1 UPF1 ATAD2 UBA6 ATP2B3 | 4.82e-04 | 614 | 220 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP40 MYCBP2 CYTH1 EPS8L1 RABGAP1 CHML TBC1D8B SLIT2 HPS4 EIF2B5 FGD3 IPO7 DOCK9 DOCK10 RACGAP1 | 5.26e-04 | 507 | 220 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP40 MYCBP2 CYTH1 EPS8L1 RABGAP1 CHML TBC1D8B SLIT2 HPS4 EIF2B5 FGD3 IPO7 DOCK9 DOCK10 RACGAP1 | 5.26e-04 | 507 | 220 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.15e-04 | 4 | 220 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.33e-04 | 140 | 220 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | alcohol binding | 9.34e-04 | 102 | 220 | 6 | GO:0043178 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.53e-04 | 18 | 220 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP6V0A1 TCIRG1 RYR1 RYR2 ITPR1 ITPR2 ITPR3 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A ATP13A4 SLC9A8 TMEM63C GRID2 OCA2 SLC25A12 ATP2B3 | 1.29e-03 | 793 | 220 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.38e-03 | 193 | 220 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.45e-03 | 151 | 220 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.57e-03 | 197 | 220 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 1.76e-03 | 6 | 220 | 2 | GO:0016778 | |
| GeneOntologyMolecularFunction | alpha-ketoglutarate transmembrane transporter activity | 1.76e-03 | 6 | 220 | 2 | GO:0015139 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.76e-03 | 6 | 220 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | RYR1 RYR2 ITPR1 ITPR2 ITPR3 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A TMEM63C GRID2 OCA2 | 1.81e-03 | 459 | 220 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | BAK1 RYR1 RYR2 ITPR1 ITPR2 ITPR3 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A TMEM63C GRID2 OCA2 | 2.13e-03 | 525 | 220 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | BAK1 RYR1 RYR2 ITPR1 ITPR2 ITPR3 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A TMEM63C GRID2 OCA2 | 2.17e-03 | 526 | 220 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | prolactin receptor binding | 2.45e-03 | 7 | 220 | 2 | GO:0005148 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V0A1 ABCA12 TCIRG1 BCS1L SLC22A6 SLC22A8 SLC25A11 ABCC2 ATP13A4 SLC9A8 SLC35C2 SLC25A12 ATP2B3 | 2.53e-03 | 477 | 220 | 13 | GO:0022804 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 9.47e-05 | 9 | 222 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.83e-04 | 11 | 222 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.18e-04 | 114 | 222 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.52e-04 | 88 | 222 | 6 | GO:0016529 | |
| Domain | ARM-type_fold | CEP104 ATR INTS1 MROH5 CUL7 FMNL2 TRIP12 ITPR1 ITPR2 PIK3C2G EIF2B5 MROH7 ARMH3 GPRASP2 IPO7 DOCK9 APOB FMNL3 AP4E1 CTNNBL1 IPO13 LRBA AP4B1 SYMPK XPO7 | 2.31e-13 | 339 | 218 | 25 | IPR016024 |
| Domain | RIH_assoc-dom | 1.23e-09 | 6 | 218 | 5 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.23e-09 | 6 | 218 | 5 | PF08709 | |
| Domain | RIH_assoc | 1.23e-09 | 6 | 218 | 5 | PF08454 | |
| Domain | RIH_dom | 1.23e-09 | 6 | 218 | 5 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.23e-09 | 6 | 218 | 5 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.23e-09 | 6 | 218 | 5 | IPR015925 | |
| Domain | - | 1.23e-09 | 6 | 218 | 5 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.23e-09 | 6 | 218 | 5 | PF01365 | |
| Domain | ARM-like | CEP104 ATR MROH5 CUL7 TRIP12 MROH7 GPRASP2 IPO7 DOCK10 ATAD2 AP4E1 CTNNBL1 IPO13 LRBA AP4B1 SYMPK XPO7 | 1.99e-08 | 270 | 218 | 17 | IPR011989 |
| Domain | MIR | 4.97e-08 | 10 | 218 | 5 | PF02815 | |
| Domain | MIR_motif | 4.97e-08 | 10 | 218 | 5 | IPR016093 | |
| Domain | MIR | 4.97e-08 | 10 | 218 | 5 | PS50919 | |
| Domain | MIR | 4.97e-08 | 10 | 218 | 5 | SM00472 | |
| Domain | - | CEP104 ATR MROH5 CUL7 TRIP12 MROH7 IPO7 ATAD2 AP4E1 CTNNBL1 IPO13 LRBA AP4B1 SYMPK | 3.61e-07 | 222 | 218 | 14 | 1.25.10.10 |
| Domain | InsP3_rcpt-bd | 1.57e-06 | 3 | 218 | 3 | IPR000493 | |
| Domain | APC_su10/DOC_dom | 5.30e-05 | 7 | 218 | 3 | IPR004939 | |
| Domain | DOC | 5.30e-05 | 7 | 218 | 3 | PS51284 | |
| Domain | ANAPC10 | 5.30e-05 | 7 | 218 | 3 | PF03256 | |
| Domain | APC10 | 5.30e-05 | 7 | 218 | 3 | SM01337 | |
| Domain | Calx_beta | 8.41e-05 | 8 | 218 | 3 | SM00237 | |
| Domain | Calx_beta | 1.25e-04 | 9 | 218 | 3 | IPR003644 | |
| Domain | Calx-beta | 1.25e-04 | 9 | 218 | 3 | PF03160 | |
| Domain | ST7 | 1.36e-04 | 2 | 218 | 2 | PF04184 | |
| Domain | ST7 | 1.36e-04 | 2 | 218 | 2 | IPR007311 | |
| Domain | Cl_channel-K | 1.36e-04 | 2 | 218 | 2 | IPR002250 | |
| Domain | Ion_trans_dom | 3.84e-04 | 114 | 218 | 7 | IPR005821 | |
| Domain | Ion_trans | 3.84e-04 | 114 | 218 | 7 | PF00520 | |
| Domain | Ryanodine_rcpt | 4.04e-04 | 3 | 218 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.04e-04 | 3 | 218 | 2 | IPR009460 | |
| Domain | RyR | 4.04e-04 | 3 | 218 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 4.04e-04 | 3 | 218 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.04e-04 | 3 | 218 | 2 | IPR013333 | |
| Domain | Dynein_HC_stalk | 5.19e-04 | 14 | 218 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-04 | 14 | 218 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-04 | 14 | 218 | 3 | PF08393 | |
| Domain | IMPORTIN_B_NT | 5.19e-04 | 14 | 218 | 3 | PS50166 | |
| Domain | MT | 5.19e-04 | 14 | 218 | 3 | PF12777 | |
| Domain | DHC_fam | 6.43e-04 | 15 | 218 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 6.43e-04 | 15 | 218 | 3 | PF03028 | |
| Domain | IBN_N | 6.43e-04 | 15 | 218 | 3 | PF03810 | |
| Domain | Dynein_heavy_dom | 6.43e-04 | 15 | 218 | 3 | IPR004273 | |
| Domain | CBS | 7.85e-04 | 16 | 218 | 3 | SM00116 | |
| Domain | IBN_N | 7.85e-04 | 16 | 218 | 3 | SM00913 | |
| Domain | ART | 8.01e-04 | 4 | 218 | 2 | IPR000768 | |
| Domain | FAM86 | 8.01e-04 | 4 | 218 | 2 | IPR029426 | |
| Domain | EPS8_PTB | 8.01e-04 | 4 | 218 | 2 | IPR033928 | |
| Domain | V_ATPase_I | 8.01e-04 | 4 | 218 | 2 | PF01496 | |
| Domain | FAM86 | 8.01e-04 | 4 | 218 | 2 | PF14904 | |
| Domain | ART | 8.01e-04 | 4 | 218 | 2 | PS01291 | |
| Domain | V-type_ATPase_116kDa_su_euka | 8.01e-04 | 4 | 218 | 2 | IPR026028 | |
| Domain | ART | 8.01e-04 | 4 | 218 | 2 | PF01129 | |
| Domain | V-ATPase_116kDa_su | 8.01e-04 | 4 | 218 | 2 | IPR002490 | |
| Domain | Importin-beta_N | 9.45e-04 | 17 | 218 | 3 | IPR001494 | |
| Domain | AAA | 1.53e-03 | 144 | 218 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.53e-03 | 144 | 218 | 7 | IPR003593 | |
| Domain | CBS_dom | 1.54e-03 | 20 | 218 | 3 | IPR000644 | |
| Domain | CBS | 1.54e-03 | 20 | 218 | 3 | PF00571 | |
| Domain | CBS | 1.54e-03 | 20 | 218 | 3 | PS51371 | |
| Domain | SOMATOTROPIN_2 | 1.97e-03 | 6 | 218 | 2 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 1.97e-03 | 6 | 218 | 2 | PS00266 | |
| Domain | DUF3398 | 1.97e-03 | 6 | 218 | 2 | PF11878 | |
| Domain | Hormone_1 | 1.97e-03 | 6 | 218 | 2 | PF00103 | |
| Domain | DOCK_C/D_N | 1.97e-03 | 6 | 218 | 2 | IPR021816 | |
| Domain | Quino_amine_DH_bsu | 2.05e-03 | 22 | 218 | 3 | IPR011044 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.37e-06 | 19 | 169 | 5 | M47760 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.63e-06 | 130 | 169 | 10 | M27454 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 1.66e-05 | 5 | 169 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.30e-05 | 6 | 169 | 3 | M47960 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | MYH6 HIPK1 RYR1 RYR2 ITPR1 ITPR2 ITPR3 SCN3A SCN4A CORIN ATP2B3 | 3.35e-05 | 203 | 169 | 11 | M5485 |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.36e-05 | 54 | 169 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.36e-05 | 54 | 169 | 6 | MM15202 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 6.51e-05 | 36 | 169 | 5 | M39831 | |
| Pathway | WP_CHOLESTASIS | 6.71e-05 | 19 | 169 | 4 | M45520 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.35e-04 | 9 | 169 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.91e-04 | 10 | 169 | 3 | M47661 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.37e-04 | 103 | 169 | 7 | MM15196 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.60e-04 | 11 | 169 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 2.60e-04 | 11 | 169 | 3 | M27466 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.82e-04 | 27 | 169 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.26e-04 | 28 | 169 | 4 | M924 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 4.43e-04 | 13 | 169 | 3 | M39589 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.43e-04 | 13 | 169 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.43e-04 | 13 | 169 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 4.43e-04 | 13 | 169 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.43e-04 | 13 | 169 | 3 | MM14553 | |
| Pubmed | 6.18e-11 | 6 | 223 | 5 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 6.18e-11 | 6 | 223 | 5 | 25966694 | |
| Pubmed | 6.18e-11 | 6 | 223 | 5 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 6.18e-11 | 6 | 223 | 5 | 16844763 | |
| Pubmed | 2.15e-10 | 7 | 223 | 5 | 11860456 | ||
| Pubmed | 1.65e-09 | 4 | 223 | 4 | 19120137 | ||
| Pubmed | ABCA12 TCIRG1 CUL7 BCS1L RYR1 ITPR3 FASN DNAH5 SYNE1 TEP1 ADGRA2 EPHB1 | 1.62e-08 | 214 | 223 | 12 | 22199357 | |
| Pubmed | CCT3 MYCBP2 INTS1 URB2 CUL7 ANKHD1 TRIP12 ITPR3 FASN TJP2 ANKRD52 IPO7 UPF1 ATAD2 TSR1 UTP4 GEMIN4 SYMPK XPO7 | 5.38e-08 | 653 | 223 | 19 | 22586326 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.13e-07 | 8 | 223 | 4 | 19033399 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.51e-07 | 38 | 223 | 6 | 30786075 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 MCMBP ATP6V0A1 ATR CCT3 URB2 ANKHD1 FASN EIF2B5 SLC25A11 DNAH5 DNHD1 IPO7 NSF DYNC2H1 SYNE1 APOB UPF1 ATAD2 KHDRBS1 TSR1 UTP4 CTNNBL1 UBA6 GEMIN4 RACGAP1 GALNT5 ATP2B3 | 1.57e-07 | 1425 | 223 | 28 | 30948266 |
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 10874040 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 20395455 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 17437169 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 18547250 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 36350267 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 11413485 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 21778422 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.60e-07 | 3 | 223 | 3 | 1693919 | |
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 23955339 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.60e-07 | 3 | 223 | 3 | 24904548 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.60e-07 | 3 | 223 | 3 | 9858485 | |
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 9808793 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 18194433 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.60e-07 | 3 | 223 | 3 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.60e-07 | 3 | 223 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.60e-07 | 3 | 223 | 3 | 18241669 | |
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 19068129 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 17327232 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 23223241 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 16014380 | ||
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 17890015 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 2.60e-07 | 3 | 223 | 3 | 9986730 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.60e-07 | 3 | 223 | 3 | 23983250 | |
| Pubmed | 2.60e-07 | 3 | 223 | 3 | 20427533 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR CCT3 ERCC6L INTS1 TRIP12 STAB1 FASN TAOK1 IPO7 NSF UPF1 PCF11 KHDRBS1 GEMIN4 RACGAP1 CDC20 SYMPK | 2.62e-07 | 582 | 223 | 17 | 20467437 |
| Pubmed | Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. | 5.24e-07 | 11 | 223 | 4 | 18341993 | |
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 25215520 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.04e-06 | 4 | 223 | 3 | 23413940 | |
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 9607712 | ||
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 31691080 | ||
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 11163362 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 1.04e-06 | 4 | 223 | 3 | 21424589 | |
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 28615414 | ||
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 10828023 | ||
| Pubmed | 1.04e-06 | 4 | 223 | 3 | 28419336 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 1.04e-06 | 4 | 223 | 3 | 35494252 | |
| Pubmed | MCMBP CCT3 MYCBP2 CUL7 PTP4A1 ITPR1 ITPR2 ITPR3 SEC24B ANKRD52 IPO7 ST7 CASK PCF11 CNNM1 TBC1D31 TSR1 TLE3 HGS TANC1 SSH2 SYMPK | 1.28e-06 | 1049 | 223 | 22 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PRPS2 HAUS6 PSEN2 ATR INTS1 TCIRG1 STAT6 SEPTIN8 NOTCH2 NSF DYNC2H1 ST7 APOB LDLR NPLOC4 SLC35F5 TMTC4 IPO13 SEPTIN11 LRBA ADPGK SYMPK | 1.54e-06 | 1061 | 223 | 22 | 33845483 |
| Pubmed | 1.81e-06 | 32 | 223 | 5 | 19542561 | ||
| Pubmed | Intracellular calcium-release channels: regulators of cell life and death. | 2.58e-06 | 5 | 223 | 3 | 9124414 | |
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 8081710 | ||
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 23918386 | ||
| Pubmed | 2.58e-06 | 5 | 223 | 3 | 15613488 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 2.58e-06 | 5 | 223 | 3 | 21568942 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ATP6V0A1 ERCC6L URB2 TRIP12 ITPR3 FZD6 SLIT2 FASN SEC24B EIF2B5 COG5 GPRASP2 IPO7 NSF DYNC2H1 UPF1 SLC25A12 GEMIN4 SYMPK XPO7 | 3.32e-06 | 942 | 223 | 20 | 31073040 |
| Pubmed | HAUS6 MYCBP2 RABGAP1 ANKHD1 FASN ANKRD52 GPRASP2 KDM5A WDR26 NOL4L TLE3 GEMIN4 LRBA | 3.53e-06 | 418 | 223 | 13 | 34709266 | |
| Pubmed | GAK MCMBP ATP6V0A1 MYCBP2 BCS1L ITPR1 ITPR2 ITPR3 ANKRD52 NOTCH2 MAPKAP1 FRAS1 IPO7 NSF DYNC2H1 ST7 SYNE1 UPF1 CASK PCF11 TBC1D31 TSR1 UTP4 HGS UBA6 TANC1 | 3.86e-06 | 1487 | 223 | 26 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZBTB16 MYCBP2 RABGAP1 ADGRV1 ZNF461 ANAPC10 NOTCH2 SLC9A8 B3GNTL1 MAN2B2 ST7 TMEM63C PPHLN1 CHST11 ZSWIM6 TEP1 NPLOC4 CASK SLC35F5 TLE3 UBA6 SEPTIN11 TANC1 GREB1 LRBA XPO7 | 3.95e-06 | 1489 | 223 | 26 | 28611215 |
| Pubmed | KNTC1 HAUS6 CUL7 FMNL2 TRIM66 TAOK1 PRMT7 PCDH18 SLC9A8 MAN2B2 DYNC2H1 PCF11 UTP4 SSH2 | 4.23e-06 | 493 | 223 | 14 | 15368895 | |
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 5.13e-06 | 6 | 223 | 3 | 21762810 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.89e-06 | 202 | 223 | 9 | 33005030 | |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 7.13e-06 | 72 | 223 | 6 | 25917818 | |
| Pubmed | GAK PSEN2 ERCC6L MYCBP2 INTS1 ITPR1 ITPR2 ITPR3 FASN COG5 NOTCH2 IPO7 DOCK9 DOCK10 CHST11 LDLR KHDRBS1 CD48 CTNNBL1 GEMIN4 LRBA ADPGK | 7.15e-06 | 1168 | 223 | 22 | 19946888 | |
| Pubmed | GAK CCT3 ANKHD1 FASN SEC24B SLC25A11 GPRASP2 NOTCH2 IPO7 NPLOC4 KHDRBS1 HGS LRBA | 7.62e-06 | 449 | 223 | 13 | 31732153 | |
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 8.93e-06 | 7 | 223 | 3 | 22495310 | |
| Pubmed | URB2 TRIP12 IPO7 NMNAT1 SYNE1 PPHLN1 UPF1 ATAD2 TSR1 UTP4 RACGAP1 | 1.12e-05 | 332 | 223 | 11 | 25693804 | |
| Pubmed | 1.18e-05 | 216 | 223 | 9 | 31519766 | ||
| Pubmed | SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. | 1.42e-05 | 8 | 223 | 3 | 23580231 | |
| Pubmed | 1.63e-05 | 225 | 223 | 9 | 12168954 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EPS8 ERCC6L FMNL2 FZD6 ABCC2 PCDH18 NOTCH2 MAPKAP1 DOCK9 APOB ATAD2 CASK TANC1 LRBA | 2.11e-05 | 569 | 223 | 14 | 30639242 |
| Pubmed | 2.12e-05 | 9 | 223 | 3 | 25737585 | ||
| Pubmed | ATR ERCC6L ANKHD1 ITPR1 EIF2B5 SLC25A11 MAPKAP1 FRAS1 UBE3B DOCK10 NPLOC4 TSR1 RACGAP1 TANC1 AP4B1 | 2.25e-05 | 650 | 223 | 15 | 38777146 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | CCT3 CYTH1 EPS8L1 ST7L ANKHD1 TRIP12 RYR1 ITPR2 SEPTIN8 SLC25A11 ABCC2 NMNAT1 NSF ST7 SLC25A12 KHDRBS1 | 2.31e-05 | 732 | 223 | 16 | 34732716 |
| Pubmed | FBXW12 CYP27B1 ANKHD1 TRIP12 STAT6 ITPR1 MEN1 SEPTIN8 CLCNKA TJP2 TAOK1 COG5 PCDH18 DOCK9 APOB LDLR NOL4L TBC1D31 TSR1 SEPTIN11 | 2.54e-05 | 1084 | 223 | 20 | 11544199 | |
| Pubmed | 2.57e-05 | 183 | 223 | 8 | 23956138 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 ERCC6L MYCBP2 BAK1 LXN PTP4A1 MEN1 SEPTIN8 EIF2B5 TJP2 NSF TGFB1I1 SLC25A12 TSR1 TLE3 GEMIN4 RACGAP1 SEPTIN11 LRBA AP4B1 CDC20 XPO7 | 3.04e-05 | 1284 | 223 | 22 | 17353931 |
| Pubmed | ZBTB16 MYCBP2 HIPK1 FMNL2 TRIP12 RYR2 NOTCH2 CASK TGFB1I1 FMNL3 KHDRBS1 CSH1 CSH2 UBA6 | 3.19e-05 | 591 | 223 | 14 | 15231748 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 3.31e-05 | 57 | 223 | 5 | 23788249 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 CYTH1 INTS1 ANKHD1 RYR1 ITPR2 ITPR3 FASN CHST15 NOTCH2 FRAS1 DOCK9 UBE3B TEP1 ADGRA2 LDLR PCNX1 TANC1 LRBA SYMPK | 3.32e-05 | 1105 | 223 | 20 | 35748872 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPS8 ATP6V0A1 CCT3 EPS8L1 ADGRV1 RYR1 SLIT2 SLC22A6 FASN SLC22A8 PTPRO TAOK1 SERPINA7 DNHD1 REXO5 DYNC2H1 ATAD2 HGS GEMIN4 | 3.40e-05 | 1016 | 223 | 19 | 19056867 |
| Pubmed | 3.45e-05 | 29 | 223 | 4 | 15037319 | ||
| Pubmed | PRPS2 ATP6V0A1 ERCC6L GOLPH3 SEC24B TJP2 MAPKAP1 PPHLN1 WDR26 SEPTIN11 TANC1 | 3.68e-05 | 378 | 223 | 11 | 34315543 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCT3 MYCBP2 INTS1 URB2 CUL7 TRIP12 ITPR2 ITPR3 SLIT2 FASN TJP2 IPO7 NSF SYNE1 KHDRBS1 UTP4 UBA6 RACGAP1 XPO7 | 3.78e-05 | 1024 | 223 | 19 | 24711643 |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 11947895 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 14967814 | ||
| Pubmed | [A genetic and clinical study in a family with familial hypercholesterolemia]. | 4.09e-05 | 2 | 223 | 2 | 21418831 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 4.09e-05 | 2 | 223 | 2 | 9065779 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 36709358 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 35145523 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 4.09e-05 | 2 | 223 | 2 | 27335120 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 7488101 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 22353362 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 8812470 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 23196129 | ||
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 25919862 | ||
| Pubmed | A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. | 4.09e-05 | 2 | 223 | 2 | 22338083 | |
| Pubmed | 4.09e-05 | 2 | 223 | 2 | 15890645 | ||
| Interaction | C3orf18 interactions | KNTC1 ATR INTS1 EIF2B5 ARMH3 DYNC2H1 GEMIN4 LRBA ATP2B3 XPO7 | 4.55e-07 | 115 | 216 | 10 | int:C3orf18 |
| Interaction | RAB29 interactions | 5.13e-06 | 89 | 216 | 8 | int:RAB29 | |
| Interaction | RASEF interactions | 6.02e-06 | 25 | 216 | 5 | int:RASEF | |
| Cytoband | 12p13-p12 | 1.41e-04 | 4 | 224 | 2 | 12p13-p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 2.42e-04 | 113 | 224 | 5 | chr12p12 | |
| Cytoband | 12p11 | 8.34e-04 | 9 | 224 | 2 | 12p11 | |
| Cytoband | 17q25 | 9.20e-04 | 39 | 224 | 3 | 17q25 | |
| Cytoband | 17p13.3 | 9.34e-04 | 88 | 224 | 4 | 17p13.3 | |
| Cytoband | 4q31 | 1.04e-03 | 10 | 224 | 2 | 4q31 | |
| Cytoband | 2q24 | 1.27e-03 | 11 | 224 | 2 | 2q24 | |
| Cytoband | 1p13.2 | 1.49e-03 | 46 | 224 | 3 | 1p13.2 | |
| Cytoband | 13q33.1 | 1.51e-03 | 12 | 224 | 2 | 13q33.1 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 5.83e-07 | 3 | 152 | 3 | 297 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.09e-04 | 3 | 152 | 2 | 287 | |
| GeneFamily | Growth hormone family | 1.03e-03 | 6 | 152 | 2 | 1175 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-08 | 124 | 224 | 9 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-08 | 130 | 224 | 9 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-08 | 193 | 224 | 10 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.38e-07 | 190 | 224 | 9 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.60e-07 | 198 | 224 | 9 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.60e-07 | 198 | 224 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.95e-06 | 165 | 224 | 8 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.95e-06 | 165 | 224 | 8 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 169 | 224 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.69e-06 | 121 | 224 | 7 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-06 | 183 | 224 | 8 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.34e-06 | 130 | 224 | 7 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 184 | 224 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.00e-06 | 192 | 224 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 6.00e-06 | 192 | 224 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.48e-06 | 194 | 224 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-06 | 196 | 224 | 8 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.98e-06 | 196 | 224 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.52e-06 | 198 | 224 | 8 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.80e-06 | 199 | 224 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.80e-06 | 199 | 224 | 8 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.09e-06 | 200 | 224 | 8 | e957f5926675f6c29208cfc3203a19dab538df38 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.09e-06 | 200 | 224 | 8 | 2ea33ac1970791e6a601ac1e407ef32e4833792d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.09e-06 | 200 | 224 | 8 | 7b3284bf0000e14f5a51e4422231e5639a184579 | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 1.06e-05 | 149 | 224 | 7 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-05 | 152 | 224 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 1.32e-05 | 154 | 224 | 7 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 159 | 224 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 159 | 224 | 7 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 164 | 224 | 7 | 583dda853cee9491dbdcb228c23d8deadc20eb08 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 2.06e-05 | 165 | 224 | 7 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 167 | 224 | 7 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-05 | 172 | 224 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.79e-05 | 173 | 224 | 7 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 174 | 224 | 7 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.90e-05 | 174 | 224 | 7 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.00e-05 | 175 | 224 | 7 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 175 | 224 | 7 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 175 | 224 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-05 | 179 | 224 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.47e-05 | 179 | 224 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-05 | 182 | 224 | 7 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 3.99e-05 | 183 | 224 | 7 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-05 | 183 | 224 | 7 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 183 | 224 | 7 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-05 | 185 | 224 | 7 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-05 | 185 | 224 | 7 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.28e-05 | 185 | 224 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-05 | 185 | 224 | 7 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 186 | 224 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 186 | 224 | 7 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.43e-05 | 186 | 224 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 187 | 224 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 188 | 224 | 7 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.74e-05 | 188 | 224 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 188 | 224 | 7 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.89e-05 | 79 | 224 | 5 | 4c9c3051cb8a9c39c6df20e3fe37242db4b44280 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.89e-05 | 79 | 224 | 5 | eddad041c0bc6952d9c68a36bdd78f6d661f0e58 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 189 | 224 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.08e-05 | 130 | 224 | 6 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.19e-05 | 80 | 224 | 5 | d42b72ef822f731ff5ff1d04216e91f414c5556e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Man1a_(Man1a)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.19e-05 | 80 | 224 | 5 | d3ee8fc9b2cb47ee476f4cd8b9fcba14cb9ca759 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.24e-05 | 191 | 224 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 191 | 224 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 192 | 224 | 7 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.41e-05 | 192 | 224 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.41e-05 | 192 | 224 | 7 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 195 | 224 | 7 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 5.97e-05 | 195 | 224 | 7 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.97e-05 | 195 | 224 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.16e-05 | 196 | 224 | 7 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.16e-05 | 196 | 224 | 7 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.16e-05 | 196 | 224 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.36e-05 | 197 | 224 | 7 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-05 | 198 | 224 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.57e-05 | 198 | 224 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.57e-05 | 198 | 224 | 7 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.57e-05 | 198 | 224 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 6.78e-05 | 199 | 224 | 7 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.78e-05 | 199 | 224 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.00e-05 | 200 | 224 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.00e-05 | 200 | 224 | 7 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.00e-05 | 200 | 224 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.00e-05 | 200 | 224 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.00e-05 | 200 | 224 | 7 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.00e-05 | 200 | 224 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.00e-05 | 200 | 224 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.00e-05 | 200 | 224 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.00e-05 | 200 | 224 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.19e-05 | 88 | 224 | 5 | fcc15c5c30517c63a835b28627c5f779d9bcd17e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.19e-05 | 88 | 224 | 5 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.19e-05 | 88 | 224 | 5 | 7838c65160cf81c02b923fc34f566c0610c8d81b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 148 | 224 | 6 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 152 | 224 | 6 | b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 155 | 224 | 6 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 157 | 224 | 6 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 162 | 224 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 162 | 224 | 6 | 3395e4dffdb9304d157c325e1fc0f12b433c7bd3 | |
| Drug | T0702 | 1.19e-07 | 25 | 221 | 6 | CID000005908 | |
| Drug | XeC compound | 1.27e-07 | 84 | 221 | 9 | CID000005701 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.96e-07 | 7 | 221 | 4 | CID009547999 | |
| Drug | Br2BAPTA | 2.96e-07 | 7 | 221 | 4 | CID003081001 | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | EPS8L1 CHML TBC1D8B ITPR1 TRIM66 HPS4 PRMT7 GOLGA1 UPF1 GEMIN4 SEPTIN11 PCNX1 | 5.15e-07 | 196 | 221 | 12 | 2080_UP |
| Drug | indo-1 | 5.28e-07 | 99 | 221 | 9 | CID000105060 | |
| Drug | verapamil | MYH6 ABCA12 RYR1 RYR2 ITPR1 ITPR3 SLC22A8 SCN3A KCNJ13 SCN4A ABCC2 APOF APOB SIRT6 LDLR ART1 ART4 ATP2B3 | 1.57e-06 | 490 | 221 | 18 | CID000002520 |
| Drug | AC1L9GJJ | 2.28e-06 | 40 | 221 | 6 | CID000444570 | |
| Drug | R 478 | 2.70e-06 | 11 | 221 | 4 | CID000084223 | |
| Drug | 8-amino-cADPR | 2.70e-06 | 11 | 221 | 4 | CID003081323 | |
| Drug | fluo-3 | 3.07e-06 | 122 | 221 | 9 | CID000104978 | |
| Drug | dihydropyridine | MYH6 RYR1 RYR2 ITPR1 ITPR3 SCN4A SIRT6 ART1 ART4 LRBA ATP2B3 | 3.11e-06 | 193 | 221 | 11 | CID000104822 |
| Drug | JBP 485 | 3.58e-06 | 4 | 221 | 3 | ctd:C412308 | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; HL60; HG-U133A | ATP6V0A1 HIPK1 PTP4A1 ITPR1 STAB1 NOTCH2 KDM5A SIRT6 ADGRA2 SLC25A12 CFAP74 | 3.98e-06 | 198 | 221 | 11 | 1411_DN |
| Drug | 6-carboxyfluorescein | 8.89e-06 | 5 | 221 | 3 | ctd:C024098 | |
| Drug | TMB-8 | 9.03e-06 | 176 | 221 | 10 | CID000005494 | |
| Drug | Gvapspat amide | 1.08e-05 | 15 | 221 | 4 | CID000125015 | |
| Drug | Fura-2AM | 1.18e-05 | 79 | 221 | 7 | CID000105091 | |
| Drug | Bay K 8644 | 1.65e-05 | 150 | 221 | 9 | CID000002303 | |
| Drug | AC1Q7BER | 1.77e-05 | 6 | 221 | 3 | CID000005702 | |
| Drug | ADP-ribosyl-L-arginine | 1.77e-05 | 6 | 221 | 3 | CID000000493 | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | RABGAP1 NOTCH2 FRAS1 B3GNTL1 KDM5A UBE3B SIRT6 TEP1 PCNX1 SYMPK | 1.84e-05 | 191 | 221 | 10 | 2789_DN |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.85e-05 | 233 | 221 | 11 | CID000005114 | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | ATP6V0A1 EPS8L1 TBC1D8B STC1 SERPINI2 PTPRO UBE3B ADGRA2 LDLR KHDRBS1 | 2.11e-05 | 194 | 221 | 10 | 6385_UP |
| Drug | AC1MIZ8I | 2.11e-05 | 35 | 221 | 5 | CID003082654 | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.20e-05 | 195 | 221 | 10 | 4355_UP | |
| Drug | isocitrate | 2.26e-05 | 156 | 221 | 9 | CID000001198 | |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | TCIRG1 PRUNE1 SEPTIN8 PRMT7 B3GNTL1 UBE3B SLC35C2 GEMIN4 PCNX1 ZNF304 | 2.40e-05 | 197 | 221 | 10 | 6296_DN |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | MCMBP EPS8L1 STC1 SEPTIN8 HPS4 DYNC2H1 SYNE1 UBE3B TEP1 LDLR | 2.40e-05 | 197 | 221 | 10 | 7069_DN |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | RABGAP1 HPS4 PRMT7 ARMH3 ALOX15 DYNC2H1 TSR1 UBA6 PCNX1 GREB1 | 2.40e-05 | 197 | 221 | 10 | 6455_DN |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | EPS8L1 STC1 PRUNE1 TRIM66 HPS4 PRMT7 ARMH3 NOTCH2 CHST11 TGFB1I1 | 2.51e-05 | 198 | 221 | 10 | 5475_DN |
| Drug | mag-fura-2 | 2.79e-05 | 37 | 221 | 5 | CID000123839 | |
| Drug | 2-amino-4-phosphonobutyric acid | 2.99e-05 | 91 | 221 | 7 | CID000002207 | |
| Drug | Bendroflumethiazide | 3.07e-05 | 7 | 221 | 3 | ctd:D001539 | |
| Drug | AC1L3IY0 | 4.54e-05 | 21 | 221 | 4 | CID000089949 | |
| Drug | NSC-695672 | 4.76e-05 | 67 | 221 | 6 | CID000393593 | |
| Drug | nitrendipine | 4.83e-05 | 98 | 221 | 7 | CID000004507 | |
| Drug | strontium | 5.18e-05 | 68 | 221 | 6 | CID000104798 | |
| Drug | luzindole | 7.33e-05 | 45 | 221 | 5 | CID000122162 | |
| Drug | nimodipine | 8.85e-05 | 145 | 221 | 8 | CID000004497 | |
| Drug | AC1O43P4 | 9.31e-05 | 25 | 221 | 4 | CID006323279 | |
| Drug | adenophostin A | 9.38e-05 | 2 | 221 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 9.38e-05 | 2 | 221 | 2 | CID000001326 | |
| Drug | cefdinir | 9.38e-05 | 2 | 221 | 2 | ctd:C056814 | |
| Drug | adenophostin B | 9.38e-05 | 2 | 221 | 2 | CID000656722 | |
| Drug | cefoselis | 9.38e-05 | 2 | 221 | 2 | ctd:C079769 | |
| Drug | Cefotiam | 9.38e-05 | 2 | 221 | 2 | ctd:D015310 | |
| Drug | benzene 1,2,4-trisphosphate | 9.38e-05 | 2 | 221 | 2 | CID000192376 | |
| Drug | propranolol | RYR1 RYR2 ITPR1 ITPR3 NSF APOF APOB SIRT6 LDLR ART1 CSH1 CSH2 ART4 LRBA | 9.47e-05 | 434 | 221 | 14 | CID000004946 |
| Drug | glibenclamide | ABCA12 SLC22A6 CLCNKA CLCNKB CPT1C KCNJ13 ABCC2 APOF APOB SIRT6 ART1 ART4 LRBA | 9.92e-05 | 382 | 221 | 13 | CID000003488 |
| Drug | PCB 95 | 1.03e-04 | 10 | 221 | 3 | CID000038012 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 190 | 221 | 9 | 2619_DN | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 1.23e-04 | 194 | 221 | 9 | 4111_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.23e-04 | 194 | 221 | 9 | 5263_DN | |
| Drug | 6-benzal-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one | 1.27e-04 | 27 | 221 | 4 | CID005149021 | |
| Drug | 1vcj | 1.27e-04 | 27 | 221 | 4 | CID000449034 | |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.32e-04 | 196 | 221 | 9 | 6902_DN | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | CHML ITPR1 STC1 NOTCH2 B3GNTL1 DYNC2H1 DOCK9 TGFB1I1 SEPTIN11 | 1.38e-04 | 197 | 221 | 9 | 2306_DN |
| Drug | LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.38e-04 | 197 | 221 | 9 | 2676_UP | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.38e-04 | 197 | 221 | 9 | 1795_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A | INTS1 RABGAP1 SEPTIN8 KDM5A DYNC2H1 TEP1 SEPTIN11 PCNX1 SYMPK | 1.38e-04 | 197 | 221 | 9 | 7419_UP |
| Drug | sodium | TCIRG1 RYR1 RYR2 SLC22A6 SLC22A8 CLCNKA CLCNKB SCN3A KCNJ13 SCN4A ABCC2 SLC9A8 NSF GRID2 UPF1 SIRT6 LDLR ART1 CSH1 ART4 LRBA ATP2B3 | 1.39e-04 | 944 | 221 | 22 | CID000000923 |
| Drug | AC1L1BPL | 1.41e-04 | 11 | 221 | 3 | CID000001548 | |
| Drug | AC1L1CSR | 1.41e-04 | 11 | 221 | 3 | CID000002045 | |
| Drug | ADP-ribosylcysteine | 1.41e-04 | 11 | 221 | 3 | CID003035804 | |
| Drug | t588 | 1.41e-04 | 11 | 221 | 3 | CID000132522 | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.43e-04 | 198 | 221 | 9 | 5334_UP | |
| Drug | arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A | GDF5 ATP6V0A1 COG5 RPS6KA4 APOB SLC25A12 KHDRBS1 TSR1 CFAP74 | 1.43e-04 | 198 | 221 | 9 | 594_UP |
| Drug | cADPR | 1.48e-04 | 82 | 221 | 6 | CID000123847 | |
| Drug | C070379 | 1.48e-04 | 199 | 221 | 9 | CID003034747 | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; HL60; HG-U133A | 1.54e-04 | 200 | 221 | 9 | 1389_DN | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.54e-04 | 200 | 221 | 9 | 4176_UP | |
| Drug | lysosphingomyelin | 1.75e-04 | 160 | 221 | 8 | CID000005263 | |
| Drug | AC1NSN3X | 1.77e-04 | 54 | 221 | 5 | CID005366189 | |
| Drug | AC1L1KRB | 1.77e-04 | 54 | 221 | 5 | CID000005621 | |
| Drug | NB-598 | 1.86e-04 | 12 | 221 | 3 | CID006443223 | |
| Disease | Bartter disease type 4B | 5.28e-05 | 2 | 215 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 5.28e-05 | 2 | 215 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 5.28e-05 | 2 | 215 | 2 | 613090 | |
| Disease | Hypoxic Brain Damage | 5.28e-05 | 2 | 215 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 5.28e-05 | 2 | 215 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 5.28e-05 | 2 | 215 | 2 | C1527348 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 5.28e-05 | 2 | 215 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 5.28e-05 | 2 | 215 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 5.28e-05 | 2 | 215 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Anoxia of brain | 5.28e-05 | 2 | 215 | 2 | C0995195 | |
| Disease | Bartter disease (implicated_via_orthology) | 5.28e-05 | 2 | 215 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | macula measurement | 7.85e-05 | 189 | 215 | 8 | EFO_0008375 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 8.00e-05 | 12 | 215 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.31e-04 | 152 | 215 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | body weight | KNTC1 GDF5 CNBD1 CYTH1 RABGAP1 ADGRV1 TRIP12 ITPR1 SLIT2 TRIM66 FASN ANAPC10 PRMT7 GRID2 OCA2 ZSWIM6 NOL4L TBC1D31 DACH2 CSH2 XPO7 EPHB1 | 1.46e-04 | 1261 | 215 | 22 | EFO_0004338 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.58e-04 | 3 | 215 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.58e-04 | 3 | 215 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | retinal nerve fibre layer thickness measurement | 2.71e-04 | 43 | 215 | 4 | EFO_0600004 | |
| Disease | Severe intellectual disability and progressive spastic paraplegia | 3.14e-04 | 4 | 215 | 2 | C4755264 | |
| Disease | liver fibrosis measurement | 4.23e-04 | 86 | 215 | 5 | EFO_0010576 | |
| Disease | Atrial Septal Defects | 5.21e-04 | 5 | 215 | 2 | C0018817 | |
| Disease | oculocutaneous albinism (implicated_via_orthology) | 5.21e-04 | 5 | 215 | 2 | DOID:0050632 (implicated_via_orthology) | |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 5.21e-04 | 5 | 215 | 2 | DOID:0110942 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 5.21e-04 | 5 | 215 | 2 | DOID:0060872 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy | 5.76e-04 | 92 | 215 | 5 | EFO_0000538 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.94e-04 | 195 | 215 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | alcoholic pancreatitis | 7.69e-04 | 98 | 215 | 5 | EFO_1002013 | |
| Disease | 3-hydroxyisobutyrate measurement | 7.78e-04 | 6 | 215 | 2 | EFO_0010983 | |
| Disease | clubfoot (implicated_via_orthology) | 7.78e-04 | 6 | 215 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | Bartter syndrome | 7.78e-04 | 6 | 215 | 2 | cv:C0004775 | |
| Disease | retinal layer thickness measurement | 9.71e-04 | 60 | 215 | 4 | EFO_0600002 | |
| Disease | LDL cholesterol change measurement | 1.08e-03 | 7 | 215 | 2 | EFO_0007804 | |
| Disease | Solid Neoplasm | 1.08e-03 | 7 | 215 | 2 | C0280100 | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 1.08e-03 | 7 | 215 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 1.09e-03 | 28 | 215 | 3 | EFO_0600005 | |
| Disease | eye colour measurement | 1.14e-03 | 218 | 215 | 7 | EFO_0009764 | |
| Disease | Familial hypercholesterolemia | 1.44e-03 | 8 | 215 | 2 | cv:C0020445 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 1.44e-03 | 8 | 215 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | female fertility, fertility measurement | 1.77e-03 | 33 | 215 | 3 | EFO_0006918, EFO_0006923 | |
| Disease | executive function measurement | 1.85e-03 | 376 | 215 | 9 | EFO_0009332 | |
| Disease | Myopia | 2.17e-03 | 385 | 215 | 9 | HP_0000545 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.29e-03 | 10 | 215 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 2.29e-03 | 10 | 215 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.29e-03 | 10 | 215 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.29e-03 | 10 | 215 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Corneal astigmatism | 2.45e-03 | 77 | 215 | 4 | EFO_1002040 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 2.78e-03 | 11 | 215 | 2 | EFO_0801871 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 2.78e-03 | 11 | 215 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | small cell lung carcinoma | 2.81e-03 | 80 | 215 | 4 | EFO_0000702 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.87e-03 | 39 | 215 | 3 | EFO_0022332 | |
| Disease | free cholesterol in medium LDL measurement | 3.09e-03 | 40 | 215 | 3 | EFO_0022268 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.32e-03 | 12 | 215 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 3.32e-03 | 12 | 215 | 2 | C0270960 | |
| Disease | cortical thickness | CNBD1 ZBTB16 MYCBP2 NUP210L RABGAP1 ADGRV1 FMNL2 STAB1 SLIT2 NSF DOCK9 PCDHB11 ADGRA2 ETV3L NOL4L UTP4 SSH2 | 3.40e-03 | 1113 | 215 | 17 | EFO_0004840 |
| Disease | migraine disorder, Headache | 3.65e-03 | 86 | 215 | 4 | HP_0002315, MONDO_0005277 | |
| Disease | Hyperlipoproteinemia Type IIb | 3.91e-03 | 13 | 215 | 2 | C1704417 | |
| Disease | descending aortic diameter | 3.97e-03 | 88 | 215 | 4 | EFO_0021788 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 4.32e-03 | 45 | 215 | 3 | EFO_0022236 | |
| Disease | cup-to-disc ratio measurement | 4.49e-03 | 430 | 215 | 9 | EFO_0006939 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 4.54e-03 | 14 | 215 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.54e-03 | 14 | 215 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | unipolar depression, anxiety | 4.54e-03 | 14 | 215 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | early cardiac repolarization measurement | 4.54e-03 | 14 | 215 | 2 | EFO_0004885 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.54e-03 | 14 | 215 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | cortical surface area measurement | GDF5 CNBD1 ZBTB16 MYCBP2 NPAS3 ADGRV1 ST7L FMNL2 SLIT2 SLC9A8 ADAMTSL1 NSF DOCK9 DOCK10 ADGRA2 NPLOC4 NOL4L SSH2 EPHB1 | 4.65e-03 | 1345 | 215 | 19 | EFO_0010736 |
| Disease | photoreceptor cell layer thickness measurement | 4.67e-03 | 148 | 215 | 5 | EFO_0803370 | |
| Disease | Disorder of eye | 4.74e-03 | 212 | 215 | 6 | C0015397 | |
| Disease | resting heart rate | 4.80e-03 | 149 | 215 | 5 | EFO_0004351 | |
| Disease | Cardiomyopathy, Dilated | 5.18e-03 | 48 | 215 | 3 | C0007193 | |
| Disease | myopathy (implicated_via_orthology) | 5.18e-03 | 48 | 215 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 5.21e-03 | 15 | 215 | 2 | EFO_0007804, GO_0036273 | |
| Disease | posterior thigh muscle volume | 5.21e-03 | 15 | 215 | 2 | EFO_0020931 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 5.49e-03 | 49 | 215 | 3 | EFO_0022256 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 5.81e-03 | 50 | 215 | 3 | C1449563 | |
| Disease | free cholesterol in LDL measurement | 5.81e-03 | 50 | 215 | 3 | EFO_0022266 | |
| Disease | Paroxysmal atrial fibrillation | 5.82e-03 | 156 | 215 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 5.82e-03 | 156 | 215 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.82e-03 | 156 | 215 | 5 | C2585653 | |
| Disease | Hyperlipoproteinemia Type IIa | 5.93e-03 | 16 | 215 | 2 | C0745103 | |
| Disease | Leber congenital amaurosis | 5.93e-03 | 16 | 215 | 2 | cv:C0339527 | |
| Disease | free cholesterol in large LDL measurement | 6.14e-03 | 51 | 215 | 3 | EFO_0022176 | |
| Disease | blood urea nitrogen measurement | 6.17e-03 | 452 | 215 | 9 | EFO_0004741 | |
| Disease | Atrial Fibrillation | 6.47e-03 | 160 | 215 | 5 | C0004238 | |
| Disease | phospholipids in IDL measurement | 6.48e-03 | 52 | 215 | 3 | EFO_0022164 | |
| Disease | generalised epilepsy | 6.48e-03 | 52 | 215 | 3 | EFO_0005917 | |
| Disease | Dementia | 6.69e-03 | 17 | 215 | 2 | C0497327 | |
| Disease | Lipidemias | 6.69e-03 | 17 | 215 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 6.69e-03 | 17 | 215 | 2 | C0020473 | |
| Disease | phospholipids in large LDL measurement | 6.84e-03 | 53 | 215 | 3 | EFO_0022174 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 6.84e-03 | 53 | 215 | 3 | EFO_0022340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDIEPHLGALFTQML | 1221 | Q14146 | |
| MIQSLTFPLALHNQS | 786 | Q68DN1 | |
| LMSSIVHQQVFPAVT | 306 | Q9BRR6 | |
| PHRSAAQMEVASFLL | 81 | Q12834 | |
| HLPQEFTDSEILQMF | 386 | Q5SZQ8 | |
| HNTLAIVENMAEFRP | 216 | Q8WYA6 | |
| SEFQTMLQHLQPTAE | 91 | Q16611 | |
| VLMPINASNALTLAH | 431 | Q96PE1 | |
| KQTNVLMHFPLSLES | 41 | Q13790 | |
| LHQFPFSSALQRMTV | 596 | Q4VNC1 | |
| SPLFMNSFHLLNQAI | 846 | Q86UK0 | |
| IVFMTTNHVDRLDPA | 326 | Q9Y276 | |
| HPEALAFTVTMQNLN | 81 | Q496F6 | |
| LHFAQGQMLATIPLT | 456 | Q8WXG9 | |
| EFHPDTLQMALQVVN | 651 | Q9Y6B7 | |
| NFITVLAQSHPEMGL | 311 | Q5T2E6 | |
| LSNHIAALKEMVVFP | 431 | Q6PL18 | |
| QASEFLLSKRHAIMP | 921 | Q96M86 | |
| HFQMAIDDQSTVILP | 546 | Q6Q4G3 | |
| ATNSALQMPLHIAAR | 956 | Q8NB46 | |
| IANMAAAAQIHSPLS | 346 | Q96NX9 | |
| MQHVAAFSLVAAPLL | 276 | Q96J87 | |
| TSIHNFMATPEFLIN | 1136 | Q16720 | |
| QDPTLALQHQMTIIE | 366 | Q9UPM8 | |
| NVSVLNHMLLTLPFF | 586 | Q68CQ1 | |
| LTPNLQHFVLHSIAM | 331 | P26374 | |
| ASLQQTQAVPLLMAH | 306 | Q04671 | |
| DNFNISPMLFRELHQ | 331 | Q96DM1 | |
| MLVNAFTEQILPHFS | 276 | Q53FA7 | |
| ARPALFDQHVVNSMV | 396 | Q8HWS3 | |
| NLIHTLAQMSAISPA | 1171 | O75747 | |
| LQDVVASLEHQFSPM | 1606 | Q14571 | |
| PGLLEAETMQHIFLN | 1256 | Q14573 | |
| PAVEQVSQLLSMLHQ | 826 | Q9HCL0 | |
| VLDNTRVPHFMQDLA | 431 | Q68EN5 | |
| VAFMVCAINPSIDLH | 241 | O00255 | |
| LLNMSHPLVHESANV | 176 | A0A2R8YFM6 | |
| APTFLMNQTDTHIVE | 1041 | Q8N7Z5 | |
| QMALAQILTHFEVQP | 466 | O15528 | |
| PLVTHFADINTFMVL | 156 | Q14994 | |
| GFANHPELQVSLFLM | 16 | Q8N0Y5 | |
| QSFLAAVLLLHMPEE | 651 | Q9Y3P9 | |
| AVLLLHMPEEQAFSV | 656 | Q9Y3P9 | |
| VLVAMTIFFNTHNEP | 281 | Q86TP1 | |
| LSEASIMGQFDHPNI | 666 | P54762 | |
| ITDNVMQHLLSPLFQ | 13951 | Q8WXI7 | |
| QHALSFSNLHEMQPL | 2196 | Q04721 | |
| EPLHSTVMVNLFVND | 831 | Q8N6Y1 | |
| ILTQPHFMALLQTHD | 431 | O14936 | |
| AMVHQLSAFQPDVVI | 231 | P0C5J1 | |
| MAETLQLNSTFLHPN | 1 | Q6IF63 | |
| RLESHMFNIAILPQT | 1446 | Q86XX4 | |
| HLDNQIFTIMITPAE | 1816 | Q86XX4 | |
| LEPTNHAVIQTLMNS | 441 | P43026 | |
| SHVTSRAMQDPVFQL | 586 | Q92805 | |
| HIMLVLPSIFNSAGV | 1591 | Q4ZG55 | |
| LQHSSELAPKFLAMV | 466 | Q8N201 | |
| LFLNPGILEAVTMQH | 1271 | Q14643 | |
| PALQAMTLALNRISH | 186 | Q9HBX8 | |
| IMQQPSLLTNHVTLA | 806 | Q86Z02 | |
| MQRILSQPTFTEHLL | 36 | Q9XRX5 | |
| SLIAAQEFDPHTVMQ | 11 | Q8WX39 | |
| QAVSLMHSEFAQLPA | 631 | Q9NQG7 | |
| AVQTVPLSRLFDHAM | 26 | P0DML3 | |
| EQVLLHLPFTMVTEQ | 1061 | Q8N6G6 | |
| QIHMAAVSQAIFAPL | 651 | Q9P1W3 | |
| LSHVVLEFPLQQMDS | 596 | Q13144 | |
| VAMVHQLSAFQPDVV | 196 | Q8N7N1 | |
| QSLADAMHIPHLFIQ | 106 | O43424 | |
| EFHFSNLVTLPQMHL | 146 | Q6X9E4 | |
| VPHSAMLFIQAAVSA | 1481 | Q96RV3 | |
| MLQNHVFPLFSSELG | 456 | O95373 | |
| SINNQMLAAEPLLSH | 521 | Q6UWM7 | |
| FQTLTPDVVHQSLFM | 701 | Q9Y468 | |
| VPAMLSHFISNDRSI | 81 | P47883 | |
| VDFSPVAVAHMNSLL | 106 | A8MUP2 | |
| LLALFAQATLSEHPM | 221 | Q14999 | |
| DFHLLLFLVTNEVMP | 506 | Q8TAT6 | |
| LFNSTQLAAMAPEHE | 231 | A0PJZ3 | |
| FAIIMLNTSLHNPNV | 191 | Q15438 | |
| NPSHFELVVFLSAMQ | 261 | O60928 | |
| SIFVHSPHALMLQDV | 441 | P50851 | |
| VLQLLVALMSEHPNS | 696 | P50851 | |
| ATLETVMATLPNFHQ | 571 | P16050 | |
| LNLPSMIHDLASQAA | 1126 | P50748 | |
| EMLNAFSTTIHVPNI | 656 | P46459 | |
| LLVTHSMHFLPQVDE | 816 | Q92887 | |
| FVAPSILFDHNNAVM | 361 | O75676 | |
| MIHFNLLETQLTPLA | 1 | A6NDL7 | |
| TPQDRHLFLFNSMIL | 386 | Q5JSP0 | |
| PHLFHNESSLVEQMI | 386 | Q9H3R1 | |
| QQPLSATVMLHLIFA | 651 | Q9Y5G1 | |
| PHLTSAMAENILAAA | 261 | Q96MY1 | |
| NELMKTLQFAVHIPT | 16 | Q9Y2T6 | |
| FESQPDLLHQLVTIM | 526 | P29375 | |
| PHTVLTFIFLEQMNK | 291 | Q02978 | |
| VANLNVLLHTLLMAP | 151 | O43749 | |
| PTANAAESILQFVHM | 1106 | Q16827 | |
| INDHSPIFSEKQMLL | 126 | Q9Y5F2 | |
| QHSDFLTQISRSPML | 1001 | Q13349 | |
| LEDLTFNSKPHINML | 26 | O94913 | |
| FNSKPHINMLTILAE | 31 | O94913 | |
| HINMLTILAEENLPF | 36 | O94913 | |
| PVSFLALHNQIRNMD | 566 | Q92900 | |
| LSTSQIPVQQMHLFD | 681 | Q8TCG5 | |
| HALMENAVQPLLTSV | 596 | Q9UP83 | |
| QSIAAVEMEHFLPLA | 51 | O60353 | |
| TVFHSLIRAMLQVNP | 286 | O14976 | |
| QFVHPTFLEMINSLL | 2716 | Q8NCM8 | |
| PTRTFMIQIAVLANH | 131 | Q9UM13 | |
| KLNDLNSVLVMPTFH | 3736 | P04114 | |
| SQPTSVMLLDFIQHI | 61 | Q13535 | |
| LVQPLKANSSVHLAM | 571 | O60308 | |
| HNLKLLQEALMPVSA | 696 | Q6ZP82 | |
| HAIMSFLPIILNQLF | 896 | Q96BY6 | |
| GHVMIAFLPTILNQL | 861 | Q9BZ29 | |
| MPQAASLHAVVVEFR | 511 | Q9NVM4 | |
| VHNNLPTTSVIMCFV | 491 | Q7Z7M9 | |
| FNLVMSHPHAVNEIA | 241 | Q8IVF7 | |
| TFGPVTLIQDAHINM | 486 | Q6TDU7 | |
| KQNFLLFDMTTHPLT | 191 | Q9H4A6 | |
| VVLGINNLDHPSVFM | 856 | Q9Y5Q5 | |
| FAESIQMLTPQLHAI | 791 | Q96PY5 | |
| PSQDMLSQALSAHAI | 401 | Q96JA4 | |
| SVQFANMDPLLDHIN | 296 | Q9Y2E5 | |
| PVLHNQREFSMADFL | 626 | Q7Z4H7 | |
| PSFTHAMQLLTAEIE | 116 | Q07666 | |
| DLVHFLFTPLNMVVQ | 356 | Q12929 | |
| FPASVSHSLMDVLQI | 3266 | Q8NDH2 | |
| SPMSHILNAKELVLN | 5516 | Q8NDH2 | |
| LHFLFGPLQMIVNTS | 346 | Q8TE68 | |
| PVGVQSELLHSMLFA | 156 | Q6ZN32 | |
| DLFLNQPHMVLSSFV | 2096 | P49327 | |
| QPHMVLSSFVLAEKA | 2101 | P49327 | |
| LQNSVLETTLMPHNY | 176 | P09326 | |
| AVQTVPLSRLFDHAM | 26 | P0DML2 | |
| MANHNLLQIFTAATP | 31 | Q8TCC7 | |
| LPNMFTNTRETHSAL | 776 | O95487 | |
| LPLLLMASHNTLQNF | 26 | Q4U2R8 | |
| VQSPELVRAMFSLLH | 2111 | P21817 | |
| FNVAVLLTNLSEHMP | 4096 | Q92736 | |
| HPDIVDSFMQLLAQA | 786 | O94829 | |
| FTPENLFLAMLSVVH | 431 | Q8NEY8 | |
| NNSLLPIKFSMHLDS | 1371 | Q9C0B2 | |
| MQLFQQHPAVLSTAE | 641 | Q8TE73 | |
| SIVDIQFLAAMIHPG | 2696 | Q8TE73 | |
| DASLVNHVLLIMPTN | 141 | Q2NKX8 | |
| QHLVPASFRLQMTIE | 411 | Q9BTE3 | |
| SEVFLQLPVEHNFAM | 1231 | Q5VU65 | |
| VIDHFICDSSPMLQL | 171 | A6NL08 | |
| MLLSLIFHNQPISLA | 81 | Q8NHC4 | |
| LLPSVAQHVVFGLQM | 466 | Q9GZU5 | |
| LLFVIQTEQSLHEPM | 51 | Q6IFG1 | |
| QSLIMQNPTADELHF | 571 | Q6ZUA9 | |
| FGNVSPEMTLVLHLA | 126 | Q9BS40 | |
| DSPDTLIMHFTQAQV | 766 | P0C091 | |
| AILQNPLSSHMQFLQ | 141 | A8MW99 | |
| AMAIAPNTNNLVIAH | 531 | Q969X6 | |
| DIHPDSMLNVFVALT | 656 | Q96DN5 | |
| FSNIMEIRQLPSSHA | 196 | Q8WV83 | |
| PMTEHFDNVLTVGNL | 601 | P35499 | |
| VAEINATMSVHLPFA | 221 | Q9NVA2 | |
| FSPNTHDSGIIMQII | 71 | Q9NYW6 | |
| FPEINLMNESSELHT | 4586 | Q8NF91 | |
| TQTLLHINFLAPLFM | 266 | Q8NDZ6 | |
| FHVLKMLLNLSENPA | 736 | Q96D09 | |
| EPTNHAIIQTLLNSM | 391 | Q7Z4P5 | |
| MAFLDNPTIILAHIR | 1 | Q9BPZ7 | |
| IAIFNALHVDPVLNM | 206 | Q9Y2E8 | |
| ALASLHPMTDEQIFQ | 761 | Q9C0D5 | |
| MSALYHIAQNESPTL | 231 | Q7L7X3 | |
| LSVAEHFLEQQMHPT | 106 | P49368 | |
| LEISSALNMFNIAPH | 3091 | O75592 | |
| VTLAMQSNLLPNAHA | 836 | Q8IXF0 | |
| HLVNLIVMDPFVDLA | 751 | Q9NY46 | |
| FPLLSMFNIHENLLE | 326 | Q9NRC1 | |
| AMLTFLHEPAVLFNL | 91 | P13533 | |
| FESARPTQTHMALVQ | 86 | Q8N6T7 | |
| PQANRDTLAFLMIHL | 466 | Q9H0H5 | |
| IGPNMASLFHILQTD | 186 | P52823 | |
| MQAHVSIILPVHNAE | 16 | Q67FW5 | |
| AMLHTNNATLRLQPF | 326 | Q8N4F0 | |
| TAHLILPEQHMSLAQ | 1556 | Q8IWZ3 | |
| SHMLTPFVEENLVSA | 191 | O75746 | |
| LPAAILSHMTAINNV | 6 | Q8NA66 | |
| PIQLELSNTAVLHQM | 66 | Q9NPF2 | |
| DFIHAFQPNARLIVM | 376 | Q7LFX5 | |
| VHALPVLMAVLAANA | 496 | P51800 | |
| VHALPVLMAVLAANA | 496 | P51801 | |
| SPQLLLATHRFMATE | 606 | Q9NRU3 | |
| ANVIANHPQMSALIT | 166 | A0A494C1R9 | |
| ELIPNDHSLMFSLAN | 646 | Q5T4D3 | |
| APLEIHTAMLALDQF | 321 | A0AVT1 | |
| ANVIANHPQMSALIT | 166 | P0CV99 | |
| ALSNHFMEFVLQVPE | 206 | Q6ZTK2 | |
| TPMEDVLHSFAVQQL | 91 | Q9UDY2 | |
| AFSLLPHEQKMSVLN | 581 | Q2NL82 | |
| LHVQPALAVSMDFST | 356 | Q05516 | |
| LRNVSTVMAPNLFLH | 421 | Q5TG30 | |
| RVPTLLQHLASMDFS | 346 | P10745 | |
| PLFQSLQISHMTQAD | 126 | Q99973 | |
| ILGQMDSPTQIFEHV | 301 | Q76I76 | |
| NTEALMTVFHPQNLE | 431 | Q0IIM8 | |
| SVNVLSAFQEPHLQM | 711 | P42226 | |
| VQSMTFVLETRQPHL | 531 | Q96IC2 | |
| MPNIVLFSGSSHQDL | 1 | P11908 | |
| LGFNLTDTPMVEIQH | 96 | P05543 | |
| SLFQSINGMHPQLLE | 441 | O14964 | |
| DNLVRPFMDTLASHQ | 431 | P49810 | |
| ELGLQNPIDTMFHLQ | 191 | Q9NQQ7 | |
| EINAVMNAHLPFAVV | 226 | Q92599 | |
| GIHIPVIMSLAQSQF | 351 | O75830 | |
| VIMSLAQSQFIANHP | 356 | O75830 | |
| IFVPHADLMSNLSQD | 1616 | Q9NY15 | |
| IAILTHQFPEIMGIF | 526 | Q8TDW4 | |
| FSPLRAIQTMHLAQN | 416 | O94813 | |
| QQAHIPNSIMTILEA | 1086 | Q92797 | |
| NTILAQIMPFLSQEH | 86 | Q04726 | |
| TSENAPSLLIHFINM | 601 | Q93050 | |
| SDNLIRPFLIHIMSV | 246 | Q7Z3V4 | |
| LHLPISETLFQMNRD | 291 | Q9HCJ5 | |
| VLTQDHMNFIASLEP | 896 | Q9UIA9 | |
| LMASLSDFRVQNHLP | 161 | O43294 | |
| FTLLDSQMTHAEVRP | 236 | Q9HCX3 | |
| NIVQEDHPIMSFTIS | 521 | Q9H7D7 | |
| VVPALITLLQMEHNF | 481 | Q14669 | |
| LVHSTFQSMPNLISD | 706 | O15016 | |
| NMRFLITHNPTNATL | 16 | Q93096 | |
| FLAQHTMLTLDPNVT | 491 | Q13488 | |
| ASAPSILIHFINMFL | 601 | Q13488 | |
| MASVNTLFQATHITP | 136 | Q9H3S4 | |
| NMPIFSQHTLLTQEF | 171 | Q8TAF7 | |
| LFLKSQEPLVSHEQM | 541 | Q9H0D2 | |
| GNMIPTINHTILFEL | 101 | P57678 | |
| LLSPEDMVLFHNLTQ | 646 | P01130 | |
| LPQNMTTTHAVAILF | 111 | Q93070 | |
| AMTAALPDLNHTEFQ | 56 | P52961 | |
| SFNPITNMHLRLFEL | 16 | Q9HAN9 |